@kahin-tai.bsky.social
Some Chinese scholar never fails to amaze me. This single-authored systematic review claims disagreements were ‘resolved by consensus,’ which must have been an intense negotiation between Me, Myself, and I. The state of peer review these days is wild.
November 15, 2025 at 2:45 PM
Some Chinese scholar never fails to amaze me. This single-authored systematic review claims disagreements were ‘resolved by consensus,’ which must have been an intense negotiation between Me, Myself, and I. The state of peer review these days is wild.
Reposted
😃 to share this new @plos.org Medicine 📄 written in collaboration with the super cool @kahin-tai.bsky.social (from the super cool @sharectd.bsky.social doctoral network), Gérard Legoff, @annelelouarn.bsky.social & @synthymama.bsky.social.
Open science must include effective results dissemination to study participants
Open science often centers around publications and data transparency. This Perspective discusses how and why disseminating results to study participants is essential for maximizing the values and bene...
journals.plos.org
October 16, 2025 at 9:08 AM
😃 to share this new @plos.org Medicine 📄 written in collaboration with the super cool @kahin-tai.bsky.social (from the super cool @sharectd.bsky.social doctoral network), Gérard Legoff, @annelelouarn.bsky.social & @synthymama.bsky.social.
Reposted
How can ORCID make research assessment more meaningful? Join Marie Curie Alumni Association on 29 Oct to see ORCID + PEP-CV in action!
🔗 Register & learn more: https://linktr.ee/orcid_org
#ORCIDintheWild #ResearchAssessment
🔗 Register & learn more: https://linktr.ee/orcid_org
#ORCIDintheWild #ResearchAssessment
October 18, 2025 at 7:35 PM
How can ORCID make research assessment more meaningful? Join Marie Curie Alumni Association on 29 Oct to see ORCID + PEP-CV in action!
🔗 Register & learn more: https://linktr.ee/orcid_org
#ORCIDintheWild #ResearchAssessment
🔗 Register & learn more: https://linktr.ee/orcid_org
#ORCIDintheWild #ResearchAssessment
Reposted
A must read work from our network. 👍
"A New Hope: SHARE-CTD trilogy concludes with data reuse"
The @sharectd.bsky.social project concludes its "trilogy" with a guide to clinical trial data reuse. In this chapter, @giulia-varvar.bsky.social introduces principles to support effective data reuse.
restores.univ-rennes.fr/highlights/n...
The @sharectd.bsky.social project concludes its "trilogy" with a guide to clinical trial data reuse. In this chapter, @giulia-varvar.bsky.social introduces principles to support effective data reuse.
restores.univ-rennes.fr/highlights/n...
September 30, 2025 at 2:04 PM
A must read work from our network. 👍
Update on my ski accident. After a thorough and well-informed discussion with my physiotherapist and surgeon, we agreed to perform a Ligamentoplastie LCA aux ischio-jambiers sous anesthésie générale. French healthcare system is quite user-friendly, highlighted by the warmth of French people :D
August 7, 2025 at 9:52 AM
Update on my ski accident. After a thorough and well-informed discussion with my physiotherapist and surgeon, we agreed to perform a Ligamentoplastie LCA aux ischio-jambiers sous anesthésie générale. French healthcare system is quite user-friendly, highlighted by the warmth of French people :D
Reposted
🎉 Kudos to Giulia @giulia-varvar.bsky.social for her speed talk at "Printemps de la Recherche" last Tuesday! She presented about SHARE-CTD, and her project on re-analysis of pivotal trials in Oncology, to Irset’s 350+ pros. A great moment to showcase open science in medicine!🔬
#SHARECTD #OpenScience
#SHARECTD #OpenScience
May 16, 2025 at 2:13 PM
🎉 Kudos to Giulia @giulia-varvar.bsky.social for her speed talk at "Printemps de la Recherche" last Tuesday! She presented about SHARE-CTD, and her project on re-analysis of pivotal trials in Oncology, to Irset’s 350+ pros. A great moment to showcase open science in medicine!🔬
#SHARECTD #OpenScience
#SHARECTD #OpenScience
Big day - my first PhD project officially kicks off!🚀 With the review team now on board, we‘re diving into how often RCTs that say they‘ll share data actually end up in IPD meta-analyses. Let’s see if intention leads to impact :D
osf.io/84wmx/
osf.io/84wmx/
SHARE-CTD - Impact of Clinical Trial Data Sharing on Data Re-use
An observational meta-research on data re-use to study the Association between Randomised Controlled Trials’ declared intent to share data and their inclusion in published Individual Participant Data ...
osf.io
May 12, 2025 at 8:58 PM
Big day - my first PhD project officially kicks off!🚀 With the review team now on board, we‘re diving into how often RCTs that say they‘ll share data actually end up in IPD meta-analyses. Let’s see if intention leads to impact :D
osf.io/84wmx/
osf.io/84wmx/
Reposted
Welcome to the official Bluesky account of SHARE-CTD!
We're a European research network dedicated to enhancing clinical trial data sharing to advance medical research and the betterment of society.
Learn more: share-ctd.eu
#SHARECTD #OpenScience #DataSharing
We're a European research network dedicated to enhancing clinical trial data sharing to advance medical research and the betterment of society.
Learn more: share-ctd.eu
#SHARECTD #OpenScience #DataSharing
NEWS
New article "The validation of prediction models deserves more recognition" published in BMC Medicine
2025.03.24
Begüm Irmak Ön and Ulrich M…
share-ctd.eu
May 2, 2025 at 10:16 AM
Welcome to the official Bluesky account of SHARE-CTD!
We're a European research network dedicated to enhancing clinical trial data sharing to advance medical research and the betterment of society.
Learn more: share-ctd.eu
#SHARECTD #OpenScience #DataSharing
We're a European research network dedicated to enhancing clinical trial data sharing to advance medical research and the betterment of society.
Learn more: share-ctd.eu
#SHARECTD #OpenScience #DataSharing
Reposted
New news story on website. "Zombie trials don't just die after retraction—they continue to pollute meta-analyses, shift effect sizes, and distort clinical guidelines. A new @bmj.com study reveals the measurable scale of this hidden contamination."
restores.univ-rennes.fr/highlights/q...
restores.univ-rennes.fr/highlights/q...
April 27, 2025 at 7:03 AM
New news story on website. "Zombie trials don't just die after retraction—they continue to pollute meta-analyses, shift effect sizes, and distort clinical guidelines. A new @bmj.com study reveals the measurable scale of this hidden contamination."
restores.univ-rennes.fr/highlights/q...
restores.univ-rennes.fr/highlights/q...
Reposted
👋, the RestoRes team is delighted to host the Embrace project on its website. While RestoRes focuses on describing challenges regarding research integrity in biomedical research, Embrace develops tools to enhance data sharing—an essential practice for trustworthy research.
restores.univ-rennes.fr
restores.univ-rennes.fr
February 18, 2025 at 1:50 PM
👋, the RestoRes team is delighted to host the Embrace project on its website. While RestoRes focuses on describing challenges regarding research integrity in biomedical research, Embrace develops tools to enhance data sharing—an essential practice for trustworthy research.
restores.univ-rennes.fr
restores.univ-rennes.fr
Reposted
New highlight in the RestoRes website: « The European Medicines Agency has published revised policies on competing interests »
The European Medicines Agency has published revised policies on competing interests | RestoRes
restores.univ-rennes.fr
February 11, 2025 at 3:22 PM
New highlight in the RestoRes website: « The European Medicines Agency has published revised policies on competing interests »
Not always can I clinically relate myself to a medical literature. After a recent fun accident on the alps, I have been looking into the rehabilitation of ACL injury.
There are so many studies and opinions out there, sometimes contradictory, which got me wondering - whose studies can I trust?
There are so many studies and opinions out there, sometimes contradictory, which got me wondering - whose studies can I trust?
Neurocognitive and Neuromuscular Rehabilitation Techniques after ACL Injury, Part 1: Optimizing Recovery in the Acute Post-Operative Phase- A Clinical Commentary
Anterior cruciate ligament (ACL) injury rates are on the rise, despite improved surgical techniques and prevention programs. While traditional rehabilitation emphasizes the restoration of motion, stre...
pmc.ncbi.nlm.nih.gov
February 3, 2025 at 10:45 PM
Not always can I clinically relate myself to a medical literature. After a recent fun accident on the alps, I have been looking into the rehabilitation of ACL injury.
There are so many studies and opinions out there, sometimes contradictory, which got me wondering - whose studies can I trust?
There are so many studies and opinions out there, sometimes contradictory, which got me wondering - whose studies can I trust?